Quality

Feb 01, 2016
Pharmaceutical Technology
Outsourcing lab analysis offers savings, while “workhorse” techniques can improve the efficiency of such core operations as stability testing.
Feb 01, 2016
BioPharm International
The recognition that microbial artifacts are capable of modulating the mammalian immune system is an emerging view of biologic drug contamination control testing.
Feb 01, 2016
BioPharm International
Understanding of the risks associated with FMEA is crucial in lot release testing.
Feb 01, 2016
By BioPharm International Editors
CDER’s Office of Pharmaceutical Quality plans on promoting modernization as a way to ensure drug quality.
Jan 27, 2016
By BioPharm International Editors
Baxter has voluntarily recalled lots of IV solutions due to potential container leakages and particulate matter.
Jan 20, 2016
By BioPharm International Editors
Abbott’s Compounding Pharmacy voluntarily recalls sterile products due to lack of sterility assurance.
Jan 06, 2016
By BioPharm International Editors
FDA issues a Warning Letter to Cadila Healthcare Limited for cGMP violations.
Jan 06, 2016
By BioPharm International Editors
The company has voluntarily recalled one lot of magnesium sulfate in water for injection because of incorrect labeling.
Jan 01, 2016
BioPharm International
Siegfried Schmitt, principal consultant, PAREXEL, discusses how to streamline the document management process during market expansion.
Jan 01, 2016
BioPharm International
The bio/pharmaceutical industry will face increased scrutiny of product quality and cost drivers.
lorem ipsum